International Consensus Recommendations on Cyclosporin Use in Rheumatoid Arthritis
- 1 January 1995
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 50 (1) , 48-56
- https://doi.org/10.2165/00003495-199500501-00008
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- CyclosporinDrugs, 1995
- Combination Therapy with Cyclosporine and Methotrexate in Severe Rheumatoid ArthritisNew England Journal of Medicine, 1995
- PHARMACOKINETICS AND TOLERABILITY OF A MICROEMULSION FORMULATION OF CYCLOSPORINE IN RENAL ALLOGRAFT RECIPIENTS—A CONCENTRATION-CONTROLLED COMPARISON WITH THE COMMERCIAL FORMULATIONTransplantation, 1994
- Improved Dose Linearity of Cyclosporine Pharmacokinetics from a Microemulsion FormulationPharmaceutical Research, 1994
- Influence of a Fat-Rich Meal on the Pharmacokinetics of a New Oral Formulation of Cyclosporine in a Crossover Comparison with the Market FormulationPharmaceutical Research, 1994
- An international consensus report: the use of cyclosporin A in rheumatoid arthritis.1993
- Renal morphology after cyclosporin A therapy in rheumatoid arthritis patients. International Kidney Biopsy Registry of Cyclosporin (Sandimmun) in Autoimmune Diseases.1993
- Regression of bone and cartilage loss in adjuvant arthritic rats after treatment with cyclosporin aArthritis & Rheumatism, 1990
- INHIBITION OF CYTOKINE PRODUCTION BY CYCLOSPORINE A AND GTransplantation, 1989
- Cyclosporine a inhibits calcemic hormone-induced bone resorption in vitroJournal of Bone and Mineral Research, 1986